The therapeutic management of hyperglycemia is known to be instrumental to avoid diabetic complications, and this is achieved by regular insulin administration in T1DM, the use of oral hypoglycemic agents in the early stages of T2DM as well as the use of insulin and also hypoglycemic agents in the later stages of T2DM [99,100]. The gene discussed is INS; the disease is Hyperglycemia.